Rationale Over-the-counter drugs containing hypericum perforatum (H. perforatum), have been argued to improve memory and sustained attention. So far, these claims have not been supported in human studies. However, previous studies used rather high dosages, and little is known about the acute effect of small dosages. Objective We evaluated whether an acute treatment with Remotiv 500 and Remotiv 250 (500 or 250 mg of H. perforatum quantified to either 1 or 0.5 mg of hypericin) improved memory, sustained attention, as well as mood and state anxiety in healthy adults. Method A single dosage, randomized, double blind, placebo-controlled trial was conducted with 82 student participants (33 women). Each participant received placebo in one session and one of two dosages in the other session. Order of the sessions and dosage conditions were randomized between subjects. Participants completed a battery of tasks assessing short-term memory capacity and sustained attention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
104
250 or 500 mg Remotiv capsules of hypericum perforatum extract, p.o.
Technion, Israel Institute of Technology
Haifa, Israel
Go/no-go task
A computerized cognitive task: aimed to measure attention and impulsivity: errors of omission and commission
Time frame: one-two hours after drug administration
Digit span task
A computerized cognitive task; accuracy of recalling
Time frame: one-two hours after drug administration
Symmetry span task
A computerized cognitive task; accuracy of responses
Time frame: one-two hours after drug administration
Operation span task
A computerized cognitive task; accuracy of responses
Time frame: one-two hours after drug administration
Groton's Maze task
A computerized task
Time frame: one-two hours after drug administration
DASS-21
A self-report questionnaire; scoring of relevant state anxiety items
Time frame: one-two hours after drug administration
PANAS
A self-report questionnaire
Time frame: one-two hours after drug administration
STAI
A self-report questionnaire; scoring of relevant state anxiety items
Time frame: one-two hours after drug administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.